Myles Minter
Stock Analyst at William Blair
(2.62)
# 2,356
Out of 5,182 analysts
25
Total ratings
57.89%
Success rate
15.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Outperform | n/a | $12.84 | - | 3 | Feb 17, 2026 | |
| NMRA Neumora Therapeutics | Upgrades: Outperform | n/a | $2.22 | - | 2 | Feb 17, 2026 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $9.59 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $2.35 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $87.16 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $9.98 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $4.44 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $783.74 | - | 2 | Nov 1, 2024 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $8.30 | +755.42% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $48.70 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $426.01 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $330.99 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $4.44 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $308.51 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $72.23 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $128.04 | -9.40% | 1 | Feb 24, 2020 |
Korro Bio
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $12.84
Upside: -
Neumora Therapeutics
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $2.22
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $9.59
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $2.35
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $87.16
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $9.98
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.44
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $783.74
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $8.30
Upside: +755.42%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $48.70
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $426.01
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $330.99
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $4.44
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $308.51
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $72.23
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $128.04
Upside: -9.40%